WILMINGTON, Mass., Oct. 6, 2014 /PRNewswire/ — Implant Sciences Corporation (IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today that the QS-B220 has successfully passed the European Civil Aviation Conference’s (ECAC) Common Evaluation Process of Security Equipment (CEP) for airport checkpoint screening of passengers and baggage. The QS-B220 is the first Explosives Trace Detector (ETD) to pass ECAC’s stringent laboratory testing protocol. The CEP was established to provide standards for security equipment performance across ECAC’s 44 member nations. The QS-B220 was also recently added to the Transportation Security Administration’s (TSA) Qualified Products List (QPL) in the U.S.

“The 44 EU member nations covered by the ECAC approval represent an enormous opportunity for Implant Sciences. Procurements across the region have been delayed while this standard was established and implemented,” stated Implant Sciences’ Vice President of Global Sales & Marketing, Dr. Darryl Jones. “As the first company to pass the new standard, we believe we are in an excellent position to capitalize on this pent-up demand.”

“Our company has achieved an unprecedented number of ETD approvals in a very short period of time, making the QS-B220 one of the most widely approved products in the world. Implant Sciences’ success is a testament to the quality product that our design team created and our manufacturing group built,” added Glenn D. Bolduc, President and CEO of Implant Sciences. “We have been gearing up in anticipation of these approvals, and we believe that we are ready to execute on these important opportunities.”